Genetic determinants of cardiovascular disease in Hispanics

被引：1

作者：

Casazza K. ^{[1
]}

Fernández J.R. ^{[1
]}

机构：

[1] Department of Nutrition Sciences, University of Alabama at Birmingham, Webb 449A, Birmingham, AL, 35294

来源：

Current Cardiovascular Risk Reports | 2009年 / 3卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Visceral Adipose Tissue; Nonalcoholic Fatty Liver Disease; Hispanic Child; Cholesterol Ester Transfer Protein; Genetic Admixture;

D O I：

10.1007/s12170-009-0028-5

中图分类号：

学科分类号：

摘要：

Cardiovascular disease (CVD) affects many people in the United States. Compared with other population groups in the United States, epidemiologic data suggest that Hispanic Americans are at a disproportionate risk for CVD. The etiology of this disparity is complex, with genetic, behavioral, cultural, and other environmental factors acting in an independent, interactive, and/or synergistic fashion. Because many complex conditions mediate risk of CVD, including diabetes, obesity, and hyperlipidemia, genes associated with these conditions have been considered as possible contributors to CVD in Hispanics. In addition, the diversity of background and heritage within this population creates a plethora of environmental determinants that interact with behaviors, cultural practices, and genetic makeup to influence disease risk. In this review, we explore the recent literature on genetic determinants of CVD and explain that effective efforts to reduce CVD disparities in Hispanics in the United States will require an understanding of the interactions of genes, the environment, and health-related practices. © 2009 Current Medicine Group, LLC.

引用

页码：175 / 180

页数：5

共 48 条

[11]

Goran M.I., Lane C., Toledo-Corral C., Weigensberg M.J., Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat, Diabetes, 57, pp. 3007-3012, (2008)

[12]

Beamer B.A., Yen C.J., Andersen R.E., Et al., Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations, Diabetes, 47, pp. 1806-1808, (1998)

[13]

Cole S.A., Mitchell B.D., Hsueh W.C., Et al., The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans, Int J Obes Relat Metab Disord, 24, pp. 522-524, (2000)

[14]

Hsueh W.C., Cole S.A., Shuldiner A.R., Et al., Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity, Diabetes Care, 24, pp. 672-677, (2001)

[15]

Black M.H., Fingerlin T.E., Allayee H., Et al., Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans, Diabetes, 57, pp. 1048-1056, (2008)

[16]

Nelson T.L., Fingerlin T.E., Moss L., Et al., The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado, Ann Nutr Metab, 51, pp. 252-257, (2007)

[17]

Moffett S.P., Feingold E., Barmada M.M., Et al., The C161→T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptor gamma, Metabolism, 54, pp. 1552-1556, (2005)

[18]

Caprio S., Hyman L.D., Limb C., Et al., Central adiposity and its metabolic correlates in obese adolescent girls, Am J Physiol, 269, 1 Pt1, (1995)

[19]

Despres J.P., Lemieux I., Abdominal obesity and metabolic syndrome, Nature, 444, pp. 881-887, (2006)

[20]

Gower B.A., Nagy T.R., Goran M.I., Visceral fat, insulin sensitivity, and lipids in prepubertal children, Diabetes, 48, pp. 1515-1521, (1999)

← 1 2 3 4 5 →